Literature DB >> 1968254

myc products induce the expression of catecholaminergic traits in quail neural crest-derived cells.

M Fauquet1, D Stehelin, S Saule.   

Abstract

The avian myelocytomatosis virus strain MC29 v-myc oncogene transforms a wide panel of avian cells in vitro and either blocks or maintains differentiation, depending on the cell type. In the present work, we have investigated the effect of this oncogene on the differentiation of early embryonic cells, neural crest cells, grown in vitro. We report that the MC29 v-myc gene product induces a strong cellular proliferation of 2-day quail neural crest with the appearance of catecholaminergic traits. Other v-myc as well as the c-myc gene products also trigger this phenotype. Retroviruses carrying some other oncogenes do not elicit this phenotypic expression, although they activate cell multiplication. Thus, our results indicate that myc gene products induce (directly or indirectly) a differentiated phenotype in a subpopulation of neural crest cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968254      PMCID: PMC53512          DOI: 10.1073/pnas.87.4.1546

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  A clonal approach to the problem of neural crest determination.

Authors:  A M Cohen; I R Konigsberg
Journal:  Dev Biol       Date:  1975-10       Impact factor: 3.582

2.  Specific RNA sequences and gene products of MC29 avian acute leukemia virus.

Authors:  P Mellon; A Pawson; K Bister; G S Martin; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

3.  Adrenergic differentiation of cells of the cholinergic ciliary and Remak ganglia in avian embryo after in vivo transplantation.

Authors:  N M Le Douarin; M A Teillet; C Ziller; J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

4.  Factors directing the expression of sympathetic nerve traits in cells of neural crest origin.

Authors:  A M Cohen
Journal:  J Exp Zool       Date:  1972-02

5.  Molecular cloning of the avian myelocytomatosis virus genome and recovery of infectious virus by transfection of chicken cells.

Authors:  B Vennström; C Moscovici; H M Goodman; J M Bishop
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

6.  Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses.

Authors:  T Graf; A von Kirchbach; H Beug
Journal:  Exp Cell Res       Date:  1981-02       Impact factor: 3.905

7.  Cellular fibronectin promotes adrenergic differentiation of quail neural crest cells in vitro.

Authors:  M Sieber-Blum; F Sieber; K M Yamada
Journal:  Exp Cell Res       Date:  1981-06       Impact factor: 3.905

8.  Differentiation of autonomic neuron precursors in vitro: cholinergic and adrenergic traits in cultured neural crest cells.

Authors:  M Fauquet; J Smith; C Ziller; N M Le Douarin
Journal:  J Neurosci       Date:  1981-05       Impact factor: 6.167

9.  Quail neural crest cells transformed by Rous sarcoma virus can be established into differentiating permanent cell cultures.

Authors:  B Pessac; C Ziller; J Vautrin; A Girard; G Calothy
Journal:  Brain Res       Date:  1985-06       Impact factor: 3.252

10.  Acetylcholine synthesis by mesencephalic neural crest cells in the process of migration in vivo.

Authors:  J Smith; M Fauquet; C Ziller; N M Le Douarin
Journal:  Nature       Date:  1979 Dec 20-27       Impact factor: 49.962

View more
  2 in total

1.  Characterization of a new melanocyte-specific gene (QNR-71) expressed in v-myc-transformed quail neuroretina.

Authors:  N Turque; F Denhez; P Martin; N Planque; M Bailly; A Bègue; D Stéhelin; S Saule
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

2.  Quail Pax-6 (Pax-QNR) mRNAs are expressed from two promoters used differentially during retina development and neuronal differentiation.

Authors:  S Plaza; C Dozier; N Turque; S Saule
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.